Adamas Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 8.69, this is below the company average, and notable indication of worsening business environment. Average collection period, for Adamas Pharmaceuticals Inc's accounts receivable remained unchanged at 42 days, in the Sep 30 2021 quarter.

If we take a look into Healthcare sector 177 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1582, from overall ranking in the second quarter 2021 at 1640.

What is Receivable Turnover Ratio?
What is Adamas Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADMS Receivables Turnover Ratio	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Receivable Change	31.35 %	52.89 %	116.13 %	39.38 %	38.15 %
Y / Y Revenue Change	28.35 %	16.91 %	33.35 %	28.52 %	44.81 %
Receivable Turnover Ratio (TTM)	8.69	8.63	9.14	10.62	10.83
ADMS's Total Ranking	# 1582	# 1640	# 1462	# 1319	# 1132
Accounts Receivable average collection period days	42	42	40	34	34
Seq. Receivable Change	-0.56 %	-18.66 %	54.45 %	5.15 %	15.74 %
Seq. Revenue Change	17.86 %	13.78 %	-8.09 %	4.13 %	7.35 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 81
Healthcare Sector	# 178
Overall Market	# 1582

Receivable Turnover Ratio Statistics
High	Average	Low
200.7	26.92	0.79
(Dec 31 2014)		(Dec 31 2016)

ADMS Company Profile • Back to ADMS Efficiency Comparisons • Compare ADMS Receivables Turnover Ratio to its Competitors

Financial Statements
Adamas Pharmaceuticals Inc's Accounts Receivable	$ 10 Millions	Visit ADMS's Balance sheet
Adamas Pharmaceuticals Inc's Sales TTM	$ 88 Millions	Visit ADMS's Income Statement
Sources of ADMS's Revenues		Visit ADMS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADMS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADMS's Growth Rates	ADMS's Roa	ADMS's Inventory Turnover Ratio	ADMS's Dividend Comparisons
ADMS's Profitability Ratios	ADMS's Roi	ADMS's Asset Turnover Ratio	ADMS's Dividend Growth
ADMS's Valuation Ratios	ADMS's Roe	ADMS's Financial Strength Ratios	ADMS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2021	Receivable at quarter ending Sep 30 2021
Notable Labs Ltd	24.09	$ 0.777 Millions	$ 0.032 Millions
Catalyst Pharmaceuticals Inc	21.80	$ 133.539 Millions	$ 6.126 Millions
Qhslab Inc	21.21	$ 1.209 Millions	$ 0.057 Millions
Catheter Precision Inc	20.81	$ 3.345 Millions	$ 0.161 Millions
Concert Pharmaceuticals Inc	20.53	$ 32.572 Millions	$ 1.587 Millions
Bridgebio Pharma Inc	20.53	$ 56.952 Millions	$ 2.775 Millions
Myovant Sciences Ltd	20.29	$ 144.949 Millions	$ 7.145 Millions
Cardiff Lexington Corporation	20.26	$ 7.059 Millions	$ 0.348 Millions
Ideaya Biosciences Inc	19.91	$ 35.550 Millions	$ 1.786 Millions
Scorpius Holdings inc	18.51	$ 2.103 Millions	$ 0.114 Millions
Reflect Scientific Inc	18.02	$ 3.665 Millions	$ 0.203 Millions
Chemed Corporation	18.02	$ 2,131.572 Millions	$ 118.281 Millions
Ethema Health Corporation	17.95	$ 1.137 Millions	$ 0.063 Millions
Neurometrix Inc	17.27	$ 8.243 Millions	$ 0.477 Millions
Aurinia Pharmaceuticals Inc	16.80	$ 72.231 Millions	$ 4.300 Millions
Sonendo Inc	16.48	$ 7.887 Millions	$ 0.479 Millions
Cv Sciences Inc	16.38	$ 20.278 Millions	$ 1.238 Millions
Innovage Holding Corp	16.20	$ 658.305 Millions	$ 40.637 Millions
Electrocore Inc	15.91	$ 4.889 Millions	$ 0.307 Millions
Merus N v	15.80	$ 43.414 Millions	$ 2.748 Millions
Precision Biosciences Inc	15.61	$ 118.036 Millions	$ 7.560 Millions
Cormedix Inc	15.18	$ 0.190 Millions	$ 0.013 Millions
Fulcrum Therapeutics Inc	15.00	$ 18.330 Millions	$ 1.222 Millions
Ultragenyx Pharmaceutical Inc	14.64	$ 359.559 Millions	$ 24.557 Millions
Patterson Companies Inc	14.49	$ 6,377.098 Millions	$ 440.188 Millions
Sangamo Therapeutics Inc	14.35	$ 108.515 Millions	$ 7.564 Millions
Inhibrx Biosciences Inc	14.28	$ 7.151 Millions	$ 0.501 Millions
Butterfly Network Inc	14.18	$ 76.148 Millions	$ 5.369 Millions
Intellia Therapeutics Inc	14.16	$ 26.794 Millions	$ 1.892 Millions
Mannkind Corporation	13.83	$ 81.370 Millions	$ 5.885 Millions

Date modified: 2026-08-29T17:26:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.